Wenwei Yang

4PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 26, 2025
Efficacy and safety of fruquintinib combined with albumin-bound paclitaxel as second-line therapy for advanced gastric cancer following failure of PD-1 inhibitor-containing treatment (TACTIC GC-01): A phase II single-arm study.

Xiaoting Ma, Kai Ou, Xiu Liu

|Nov 27, 2025
Pyrotinib Plus Trastuzumab as an Effective Later-Line Therapeutic Strategy for HER2-Positive Metastatic Colorectal Cancer: Results from a Phase II Study.

Wenwei Yang, Jing Zhang, Guifu Wu

|Oct 25, 2024
Phase II Study of Irinotecan, Trifluridine/tipiracil (TAS-102) plus Bevacizumab as a Later-line Therapy for Patients with Metastatic Colorectal Cancer (mCRC): a prospective single-center explorative study.

Baoqi Li, Wenwei Yang, Na Liu

|Mar 04, 2021
Promising Molecular Targets for the Targeted Therapy of Biliary Tract Cancers: An Overview.

Wenwei Yang, Yongkun Sun

Pageof 1

Frequent Collaborators

2 joint publications

Yongkun Sun

1 joint publications

Xiaoting Ma

1 joint publications

Lin Yang